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Volume 51, Number 11S Abstracts 19SResults: For ENDO, 36 chimney stents (1.7/patient),
8—SMA and renal, 7—bilateral renals, 5—single renal,
1—SMA, were successfully placed in 37 branches (97%); 1
renal occluded from loss of guidewire. For OPEN, there
were 15 tube and 6 aortoiliac grafts. Perioperative data are
shown in Table. Kaplan-Meier patency at 1 and 6 months
was 97.3%. There was one type 1a endoleak at 30-days.
Despite a lower preoperative eGFR in the ENDO group
(52 vs 60 mL/min/1.73m2, p  0.017) the median post-
operative change was similar (-0.5 vs 0 mL/min/1.73m2,
p  0.841); 2 OPEN, but no ENDO, patients required
dialysis.
Conclusions: Chimney technique may be a viable
option for repair of suprarenal aneurysms and an “off-
the-shelf” alternative to custom fenestrated/branched
endografts. Perioperative benefits of endovascular repair
are maintained with preservation of end organ function.
Late stent patency and proximal fixation remains to be
determined.
TABLE ENDO OPEN P
Proc Time (min) 235 213 0.65
EBL (ml) 350 1500 0.001
PRBC transfusion (units) 1 3 0.007
ICU stay (days) 1 4 0.001
Total LOS (days) 5 10 0.021
Mortality (n) 1 (4.8%) 1 (4.8%) 1.0
Adverse Events (n) 29 61
All (n/patient) 1.4 2.9 0.75
Severe (n/patient) 0.3 0.7 0.60
Author Disclosures: A. W. Beck: Nothing to disclose;
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Objectives: The Zenith Renu AAA Ancillary Graft,
which gained FDA approval in June 2005, provides active
proximal fixation for treatment of pre-existing endografts
with failed or failing proximal fixation or seal. The purpose
of this study is to evaluate the midterm outcome of treat-
ment with this device.
Methods: From 09/2005 to 11/2006, a prospective,
nonrandomized, post-market registry was implemented,
collecting experience from 151 cases (89 converters and 62
main body extensions) at 95 institutions. Preoperative in-
dications, procedural and post-implantation outcomes
were analyzed. Technical success and clinical success were
determined as defined by the SVS reporting standards.Results: Patients were predominantly male (87%)
with mean age of 77 years. The interval between the
original endograft implantation to Renu treatment was
43.4  18.7 months. The indications for treatment were
endoleak (n  108), migration (n  136), or both (n 
94). Technical success was 98% with 2 cases of intraop-
erative conversion and 1 persistent type IA endoleak.
The mean follow-up for the cohort was 18.5  12.7
months (range 0-48). Overall, 23 patients had treatment
failures which included at least one of the following: 8
type I/III endoleaks, 1 migration, 7 aneurysm enlarge-
ment 5mm, 3 aneurysm ruptures, 8 conversions (with
6 after 30 days), and 5 identified procedure-related
deaths. Overall, the clinical success for the entire cohort
during the follow-up period was 84.7%.
Conclusions: The post-market registry data confirms
that the Zenith Renu AAA Ancillary Graft can be used to
treat failed endovascular repairs from proximal attachment
failures. However, this is associated with a high rate of
midterm failure. While we can salvage failed endovascular
repairs, these results emphasize the importance of patient
and device selection during initial endovascular aneurysm
repair. In this challenging population with endovascular
graft failure, surgical conversion should be considered for
those that are medically fit for open repair.
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Objectives: Historically, women have higher mortality
rates after AAA repair than men. Although endovascular
repair (EVAR) has improved these rates, how gender affects
long-term survival after AAA repair is unknown. We ana-
lyzed survival in matched cohorts after EVAR and open
(OAR) repair for elective (eAAA) and ruptured (rAAA)
abdominal aortic aneurysm.
Methods: From the Medicare Beneficiary Database,
we compiled a cohort of patients who underwent OAR or
EVAR repair for either eAAA (n 214, 802) or rAAA (n
